MasterControl Inc. (Headquarters: Utah, USA; Japanese Subsidiary: Minato-ku, Tokyo), a leading provider of cloud-based quality management software for the medical device and life sciences industries, today released a latest trend document for leaders in the life sciences and manufacturing sectors titled '4 AI Trends Shaping the Future of Life Sciences in 2026'.
Enthusiasm for adopting AI alone does not generate ROI. The initial wave of AI experiments in the life sciences industry clearly demonstrated this. Successful organizations are approaching AI with 'concrete use cases' backed by strategic focus, robust data foundations, regulatory readiness, and measurable operational impact.
This report details the path to achieving this.
◆ 4 AI Trends Revealed in This Report 1. Agentic AI The evolution from generic chatbots to 'specialized operational copilots' dedicated to quality and manufacturing tasks. It explains use cases that deliver immediate value, such as batch record analysis and support for deviation investigations.
2. Establishment of Data Infrastructure Up to 70% of respondents state that accessing data required for AI projects is 'difficult' or 'somewhat difficult'. We specifically introduce how to build a data infrastructure that supports scalable AI deployment.
3. Evolving AI Compliance Requirements In response to mounting regulatory pressures, such as the EU AI Act and draft Annex 11/22, we present methods for building a governance framework that should be addressed immediately.
4. Innovating Quality Control through Computer Vision We introduce practical use cases of computer vision technology that visibly improve quality control operations on the manufacturing floor with proven ROI.
Keywords: Medical devices, Pharmaceuticals, QMSR, QMS, MES, GMP, FDA, PMDA, Quality Management System, AI
FACT BOX
- Source: PR TIMES
- Category: Survey